[Research progress on the role and mechanism of endothelial dysfunction in hyperhomocysteine-induced atherosclerosis]

Cheng-Yan Wu1, Xu-Lei Duan1, Li-Bo Wang1

  • 1Department of Cardiology, The First Affiliated Hospital of Xinxiang Medical University; Heart Center of Xinxiang Medical University, Xinxiang 453100, China.

Insights

High homocysteine levels (HHcy) are linked to cardiovascular disease risk. HHcy causes endothelial dysfunction through various molecular pathways, including endothelial mesenchymal transition, contributing to vascular damage.

Area of Science:

  • Cardiovascular Science
  • Molecular Biology
  • Pathophysiology

Background:

  • Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular diseases.
  • The precise molecular mechanisms linking HHcy to vascular pathogenesis remain unclear.
  • Endothelial dysfunction is a critical early event in atherosclerosis and HHcy-related vascular diseases.

Approach:

  • This review synthesizes current research on the molecular links between HHcy and endothelial dysfunction.
  • It specifically examines how HHcy impacts endothelial cells.
  • The review highlights the role of endothelial mesenchymal transition in HHcy-induced vascular damage.

Key Points:

  • HHcy induces endothelial dysfunction by promoting oxidative stress, inhibiting nitric oxide and hydrogen sulfide pathways.
  • HHcy also triggers endothelial mesenchymal transition, activates coagulation, and causes protein N-homocysteination and cellular hypomethylation.
  • Endothelial mesenchymal transition is identified as a significant contributor to HHcy-mediated vascular injury.

Conclusions:

  • HHcy contributes to vascular disease through multiple detrimental effects on endothelial cells.
  • Endothelial mesenchymal transition represents a key mechanism in HHcy-induced vascular damage.
  • Understanding these pathways may offer novel therapeutic strategies for HHcy-related vascular conditions.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
98
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
719
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
13